Status:
COMPLETED
Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar
Lead Sponsor:
Pfizer
Conditions:
Attention Deficit Disorder With Hyperactivity
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
Determine if there is a difference in treatment response for adults with ADHD who are treated with Strattera versus those treated with a combination of Strattera and buspirone
Eligibility Criteria
Inclusion
- Adults with ADHD
Exclusion
- Other Axis I Psychiatric Disorders
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2006
Estimated Enrollment :
241 Patients enrolled
Trial Details
Trial ID
NCT00174226
Start Date
November 1 2004
End Date
January 1 2006
Last Update
July 15 2008
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Los Angeles, California, United States, 90095
2
Pfizer Investigational Site
San Diego, California, United States, 92103-8218
3
Pfizer Investigational Site
San Diego, California, United States, 92103-8620
4
Pfizer Investigational Site
San Diego, California, United States, 92103-8656